Colorectal Cancer clinical trials in Nevada

10 actively recruiting colorectal cancer trials at 5 sites across Nevada.

Data from ClinicalTrials.gov · last refreshed 2026-08-10

Phase 2, Phase 3 Recruiting Academic/Other

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

Sponsor: NRG Oncology

NCT ID: NCT05174169

Sites in Nevada:

Carson Tahoe Regional Medical Center — Carson City, Nevada
Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
OptumCare Cancer Care at Charleston — Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada - Central Valley — Las Vegas, Nevada

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectum (CRC)). The goal is to understand if the new study medicine, combined with chemotherapy …

Sponsor: Pfizer

NCT ID: NCT07222800

Sites in Nevada:

Renown Health Medical Oncology — Reno, Nevada
Renown Regional Medical Center — Reno, Nevada

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limit…

Sponsor: Canadian Cancer Trials Group

NCT ID: NCT06205485

Sites in Nevada:

Renown Regional Medical Center — Reno, Nevada

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

The purpose of this study is to compare how long the participants are disease-free (progression-free survival) when treated with amivantamab and chemotherapy with 5-fluorouracil, leucovorin calcium (folinic acid) or levoleucovorin, oxalipl…

Sponsor: Janssen Research & Development, LLC

NCT ID: NCT06662786

Sites in Nevada:

Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation called KRAS G12C. Standard (or usual) treatments for this type of colorectal cancer may in…

Sponsor: Merck Sharp & Dohme LLC

NCT ID: NCT06997497

Sites in Nevada:

Renown Regional Medical Center ( Site 0056) — Reno, Nevada

View on ClinicalTrials.gov →

Phase 2 Recruiting Industry

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

A randomized study to determine safety and efficacy of a series of subcutaneous (SC) injections of HAL in patients with CINP, compared to matching placebo injections. After that, subjects may have the option to enter an Open Label extensio…

Sponsor: Dogwood Therapeutics Inc.

NCT ID: NCT06848348

Sites in Nevada:

Central Recruiting Site — Las Vegas, Nevada

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect of biomarkers of zanzalintinib administered alon…

Sponsor: Exelixis

NCT ID: NCT05176483

Sites in Nevada:

Exelixis Clinical Site #55 — Las Vegas, Nevada

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

The main purpose of this study is to evaluate the safety and preliminary efficacy of CHS-114 in combination with toripalimab and/or other standard of care (SOC) compound(s) in participants with advanced or metastatic solid tumors.

Sponsor: Coherus Oncology, Inc.

NCT ID: NCT06657144

Sites in Nevada:

Comprehensive Cancer Center of Nevada — Las Vegas, Nevada

View on ClinicalTrials.gov →

NA Recruiting Academic/Other

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared to participants randomized to surveillance colonoscopy at 5 and 10 years.

Sponsor: NRG Oncology

NCT ID: NCT05080673

Sites in Nevada:

Carson Tahoe Regional Medical Center — Carson City, Nevada
Cancer and Blood Specialists-Henderson — Henderson, Nevada
Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
Comprehensive Cancer Centers of Nevada-Horizon Ridge — Henderson, Nevada
Comprehensive Cancer Centers of Nevada-Southeast Henderson — Henderson, Nevada

View on ClinicalTrials.gov →

NA Recruiting Network

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Sponsor: Eastern Cooperative Oncology Group

NCT ID: NCT05108298

Sites in Nevada:

Carson Tahoe Regional Medical Center — Carson City, Nevada
Cancer and Blood Specialists-Henderson — Henderson, Nevada
Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
Comprehensive Cancer Centers of Nevada-Horizon Ridge — Henderson, Nevada
Las Vegas Cancer Center-Henderson — Henderson, Nevada

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-08-10